Patents/Assignees

Fulcrum Therapeutics, Inc.

3 patents in portfolio

US12109198utility2024
Macrocyclic Azolopyridine Derivatives as EED and PRC2 Modulators
0 cites
US11819554utility2023
Compositions and Methods for Modulating FMR1 Expression
0 cites
US11590111utility2023
Macrocyclic Azolopyridine Derivatives as EED and PRC2 Modulators
0 cites